• Stoke Therapeutics' (STOK) "Buy" Rating Reiterated at Chardan Capital

    Source: Buzz FX / 20 Mar 2025 08:16:17   America/New_York


    Stoke Therapeutics' (STOK) "Buy" Rating Reiterated at Chardan Capital Written by MarketBeat March 20, 2025 Share Link copied to clipboard. Remove Ads Stoke Therapeutics ( NASDAQ:STOK - Get Free Report ) 's stock had its "buy" rating restate
    Read more...
Share on,